Casa Physicians Alliance News
Sanofi TENIVAC Supply Status
Dear Healthcare Provider,
Sanofi Pasteur is experiencing a manufacturing delay with TENIVAC® (Tetanus and Diphtheria Toxoids Adsorbed) and will therefore not be able to supply TENIVAC vaccine. This supply disruption is related to unanticipated delays in manufacturing facility upgrades. It is expected that supply will improve in the second half of 2017. Please note that this does not impact the supply of Adacel ® a vaccine, Pentacel ® b vaccine, or DAPTACEL® c vaccine.
As an alternative, you may consider using a Tdap vaccine, such as Adacel vaccine, for eligible patients. The ACIP recommends that all eligible adults 19 years of age and older receive a single dose of Tdap vaccine. 1 Despite this long-standing recommendation, the CDC estimates that 78.5% of adults 19-64 years of age have not yet been vaccinated with Tdap vaccine. 2
Sanofi Pasteur recognizes the challenges we face when we are unable to obtain the vaccine of choice and the impact this has on our business . Thank you for your understanding and we look forward to continuing to partner with you for your immunization needs.
Should you require assistance locating alternative sources of Td vaccine or need additional information, please visit Sanofi Pasteur’s website at www.vaccineshoppe.com, contact your Sanofi Pasteur sales representative, or call their Customer Service representatives at 1-800-VACCINE (1-800-822-2463).
IMPORTANT SAFETY INFORMATION FOR TENIVAC VACCINE
Known hypersensitivity ( eg , anaphylaxis) to a previous dose of TENIVAC vaccine or any other tetanus or diphtheria toxoid‐containing vaccine is a contraindication. Because of uncertainty as to which component of the vaccine may be responsible, no further vaccination with diphtheria or tetanus components should be carried out.
The tip caps of the prefilled syringes may contain natural rubber latex that may cause allergic reactions in latex sensitive individuals.
If Guillain‐Barré syndrome has occurred within 6 weeks following previous vaccination with a tetanus toxoid containing vaccine, the decision to give TENIVAC vaccine should be based on careful consideration of the potential benefits and possible risks.
Persons who experienced Arthus‐type hypersensitivity reactions following a prior dose of tetanus toxoid containing vaccine should not receive TENIVAC vaccine less than 10 years since the last dose of tetanus toxoid containing vaccine.
The most common local and systemic adverse reactions to TENIVAC vaccine include erythema, tenderness, and swelling at the injection site; headache, malaise, and fever. Other adverse reactions may occur. Vaccination with TENIVAC vaccine may not protect all individuals.
INDICATION FOR TENIVAC VACCINE
TENIVAC vaccine is indicated for active immunization for prevention of tetanus and diphtheria. TENIVAC vaccine is approved for use in persons 7 years of age and older.
IMPORTANT SAFETY INFORMATION FOR ADACEL VACCINE
Known hypersensitivity ( eg, anaphylaxis) to a previous dose of Adacel vaccine or any other tetanus toxoid, diphtheria toxoid, or pertussis antigen-containing vaccine, or to any component; or encephalopathy within 7 days after a previous dose of a pertussis-containing vaccine with no other identifiable cause, is a contraindication.
The tip caps of the prefilled syringes may contain natural rubber latex that may cause allergic reactions in latex-sensitive individuals.
If Guillain-Barré syndrome or brachial neuritis has occurred within 6 weeks following previous vaccination with a tetanus toxoid-containing vaccine, if progressive or unstable neurologic disorders exist, or if adverse events have occurred in temporal relation to receipt of pertussis antigen-containing vaccine, the decision to give Adacel vaccine should be based on careful consideration of the potential benefits and risks.
Persons who experienced an Arthus-type hypersensitivity reaction following a prior dose of tetanus toxoid-containing vaccine should not receive Adacel vaccine unless at least 10 years have elapsed since the last dose of tetanus toxoid-containing vaccine.
Syncope (fainting) can occur in association with administration of injectable vaccines, including Adacel vaccine. Procedures should be in place to prevent falling injury and manage syncopal reactions.
The most common local and systemic adverse reactions to Adacel vaccine include pain, erythema, and swelling at the injection site; headache, body ache or muscle weakness, and tiredness. Other adverse reactions may occur. Vaccination with Adacelvaccine may not protect all individuals.
INDICATION FOR ADACEL VACCINE
Adacel vaccine is indicated for active booster immunization for the prevention of tetanus, diphtheria, and pertussis. Adacel vaccine is approved for use as a single dose in individuals 10 through 64 years of age.
Before administering TENIVAC or Adacel vaccine, please see full prescribing information.
a Adacel (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed). b Pentacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate [Tetanus Toxoid Conjugate] Vaccine).
cDAPTACEL (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed).
References: 1 Centers for Disease Control and Prevention (CDC). Preventing tetanus, diphtheria, and pertussis among adults: use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendations of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC) for use of Tdap among health-care personnel. MMWR. 2006 ;55(RR-17):1-37. 2. CDC. Vaccination coverage among adult population – United States, 2014. MMWR. 2016 ;61(25):468.
Posted by Shari Smith on 17th November, 2016 | Comments | Trackbacks
Tags: Tentanus and Diphtheria Toxoids Adsorbed, Pentacel, TENIVAC, Group Purchasing Organization, CASA Physicians Alliance, Adacel, Daptacel, Discount Vaccines, Discount Buying Opportunity, Discount Sanofi Vaccines, Discount Vaccine Buying Program, Discount Vaccine Program, Vaccine Discounts and Rebates, vaccine, Purchasing Program, Vaccine Group, Vaccine Savings, Sanofi, Physicians Buying Group, Savings on Pediatric Vaccines, Sanofi Pasteur, Savings on Adolescent Vaccines, Savings on Adult Vaccines
The trackback URL for this page is http://www.casa.en.asenz2biz.asenz360.com/trackback?post=32906252
There are no trackbacks for this post
There are no comments for this post
Post a Comment
HTML is not allowed in comments, http://... will be automatically linked.